aacr 2011: ovarian cancer patients with brca mutations show improved survival.
Published 13 years ago • 794 plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
3:34
aacr 2011: ovarian cancer patients with brca mutations show improved survival.
-
1:44
identifying brca mutations for breast and ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
6:19
chemosymposium 2011: parp treatment for brca mutated and triple negative breast cancer
-
4:26
more ovarian cancer patients benefit from maintenance combined targeted therapy
-
3:26
different treatment strategies for brca positive breast cancer
-
1:45
clinical trial available for women with brca1 mutations to assess reduced risk of ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
2:29
mastectomy surgery in patients with brca gene mutations — mayo clinic
-
3:41
case 2: treating brca-mutated ovarian cancer
-
50:59
considerations facing young women with a brca mutation
-
4:19
brca testing in breast and ovarian cancer
-
30:08
brca mutations and lynch syndrome
-
57:02
brca mutations and ovarian cancer: what you need to know
-
25:59
final overall survival results from the phase 3 solo2 trial for ovarian cancer